CClinicalTrials.gg
CompletedNCT02857790GlaMoRouSUpdated Aug 5, 2016

Glasgow MRI and Rotablation Study

An observational study in Coronary Artery Disease, sponsored by NHS National Waiting Times Centre Board. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-08-05.

Sponsored by NHS National Waiting Times Centre Board · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
58
Ages
18 Years and older
Sex
All
01

Study summary

Percutaneous coronary intervention (PCI) with adjunctive high speed rotational atherectomy (HSRA) is commonly used to treat complex and calcified coronary artery stenoses. Theoretically, HSRA may have deleterious effects on the coronary microcirculation and result in peri-procedural myocardial infarction (Type 4a MI).

This study is assessing the effects of HSRA PCI using serial multi-parametric stress perfusion cardiac magnetic resonance imaging (CMR) (1.5 Tesla MAGNETOM Avanto, Siemens Healthcare). The study will prospectively enrol up to 75 patients (minimum completed cohort of 50 patients) undergoing elective HSRA PCI and performing multi-parametric CMR at 3 time-points: before HSRA, 1 week post-HSRA, and 6 months post-HSRA. Myocardial perfusion will be assessed using pharmacological stress with intravenous adenosine (140 micrograms/kg/min) at each time point. High-sensitivity cardiac troponin (hsTn) and ECGs will be performed post-HSRA.

Read the detailed description

High Speed Rotational atherectomy (HSRA) is a technique used during angioplasty in the treatment of calcified coronary arteries. Rotablation debulks resistant calcium in the coronary artery plaque thus facilitating stent deployment and expansion. The atherectomy technique involves a rotating diamond-tipped burr which breaks down the calcium into small particles which are washed forward by the blood flow into the smaller coronary branches supplying the heart muscle. The dispersed calcium particles may block these smaller blood vessels, interrupting blood flow to an extent that may result in heart muscle damage. When this injury becomes detectable clinically, with symptoms, ECG changes and increased troponin, an iatrogenic type IV myocardial infarction (MI) is diagnosed.

Cardiac magnetic resonance imaging (CMR) is the gold standard method for imaging the heart providing detailed information on cardiac function and muscle injury.

This is a prospective cohort observational study of 60 patients undergoing coronary angioplasty with rotational atherectomy.

The aim of the study is to investigate myocardial injury revealed by paired CMR scans before and after rotational atherectomy.

The hypothesis is that following rotational atherectomy, displacement of calcified particles cause microvascular obstruction leading to reduced perfusion. Since myocardial perfusion and pump function are linked, as myocardial perfusion is reduced after atherectomy, so myocardial contractility (i.e. strain) will reduce. In a second analysis, computer modelling will be used to integrate the different types of CMR information to better understand the spatial, temporal and pathological evolution of myocardial infarction (www.softmech.org). The further hypothesis is that despite CMR detectable infarction the incidence of clinical type IV MI will be low.

CMR scans will be performed 1 week before, 1 week and 6 months post rotablation. Cardiac troponin and ECGs will be performed post rotablation to determine the incidence of type IV MI.

02

Conditions studied

  • Coronary Artery Disease

Keywords

  • Rotablation
  • High speed rotational atherectomy
  • Type IV myocardial infarction
  • Cardiac magnetic resonance imaging
  • CMR
  • Percutaneous Coronary Intervention
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's enrollment of 58 is below the median of 336 across 1,947 observational studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

NHS National Waiting Times Centre Board is the lead sponsor of 18 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Near consecutive eligible patients undergoing elective PCI with rotablation.

Inclusion criteria

  • Stable angina
  • Indication for PCI with rotablation

Exclusion criteria

Exclusion Criteria:

  • Other major systemic illness
  • Contra-indication to CMR
  • Pregnancy
  • CKD (eGFR\<30)
  • Pre-existing infarct in culprit vessel territory on ECG, echo or baseline CMR
  • Chronic total occlusion
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
58 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Change in circumferential myocardial strain

    Time frame: 1 week and 6 months post-rotablation

Secondary outcomes

  1. Incidence of CMR detected de novo late gadolinium enhancement

    Time frame: 1 week and 6 months post-rotablation

  2. Incidence of type IV myocardial infarction

    Time frame: 6-12 hours post-rotablation

  3. Change in ischaemic burden

    Time frame: 1 week and 6 months post-rotablation

  4. Change in left ventricular ejection fraction (LVEF)

    Time frame: 1 week and 6 months post-rotablation

  5. Change in left ventricular (LV) volumes

    Time frame: 1 week and 6 months post-rotablation

  6. Index of Microcirculatory Resistance (IMR)

    Time frame: Intra-procedural baseline, intra-procedural post-rotablation, and intra-procedural post-stenting

  7. Minimum Stent Area (MSA)

    Time frame: Intra-procedural post-rotablation

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02857790
Lead sponsor
NHS National Waiting Times Centre Board
Collaborators
University of Glasgow, Cardiovascular Research Foundation, New York, Medical Research Scotland, Chief Scientist Office of the Scottish Government, Scottish Funding Council, Engineering and Physical Sciences Research Council (EPSRC)
Responsible party
Margaret McEntegart (Consultant Cardiologist, NHS National Waiting Times Centre Board) — Principal investigator
First posted
Aug 5, 2016
Start date
Mar 2012
Primary completion
Jan 2016
Completion
Jun 2016
Last update
Aug 5, 2016

Study contacts

Margaret McEntegart
principal investigator · Golden Jubilee National Hospital
Colin Berry
principal investigator · University of Glasgow

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion